Dose-dependent effects of FK506 on neuroregeneration in a rat model

Plastic and Reconstructive Surgery

Volumn 112, Issue 7, 2003, Pages 1832-1840

  Yang, Roberta K ^a,b   Lowe III, James B ^a,b   Sobol, Julia B ^a,b   Sen, Subhro K ^a,b   Hunter, Daniel A ^a,b   Mackinnon, Susan E ^a,b  

^a Washington Univ School of Medicine ^*

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; LOW DRUG DOSE; MALE; MORPHOMETRICS; NERVE DEGENERATION; NERVE REGENERATION; NERVE TRANSECTION; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SKIN ALLOGRAFT; TIBIAL NERVE; ANIMAL; LEWIS RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; MODELS, ANIMAL; NERVE REGENERATION; RATS; RATS, INBRED LEW; TACROLIMUS;

EID: 0642333766     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000091167.27303.18     Document Type: Article

References (41)

1. Steiner, J. P., Hamilton, G. S., Ross, D. T., et al. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. U.S.A. 94: 2019, 1997.
2. Kobayashi, J., Mackinnon, S. E., Watanabe, O., et al. The effect of duration of muscle denervation on functional recovery in the rat model. Muscle Nerve 20: 858, 1997.
3. Kino, T., Hatanaka, H., Miyata, S., et al. FK-506, a novel immunosuppressant isolated from a Streptomyces: II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. (Tokyo) 40: 1256, 1987.
4. Starzl, T. E., Todo, S., Fung, J., Demetris, A. J., Venkataramman, R., and Jain, A. FK506 for liver, kidney, and pancreas transplantation. Lancet 2: 1000, 1989.
5. Doolabh, V. B., and Mackinnon, S. E. FK506 accelerates functional recovery following nerve grafting in a rat model. Plast. Reconstr. Surg. 103: 1928, 1999.
6. Fansa, H., Keilhoff, G., Altmann, S., Plogmeier, K., Wolf, G., and Schneider, W. The effect of the immunosuppressant FK506 on peripheral nerve regeneration following nerve grafting. J. Hand Surg. (Br.) 24: 38, 1999.
7. Gold, B. G., Katoh, K., and Storm-Dickerson, T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 15: 7509, 1995.
8. Jost, S. C., Doolabh, V. B., Mackinnon, S. E., Lee, M., and Hunter, D. Acceleration of peripheral nerve regeneration following FK506 administration. Restor. Neurol. Neurosci. 17: 39, 2000.
9. Lee, M., Doolabh, V. B., Mackinnon, S. E., and Jost, S. FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve 23: 633, 2000.
10. Gold, B. G. FK506 and the role of immunophilins in nerve regeneration. Mol. Neurobiol. 15: 285, 1997.
11. Gold, B. G., Densmore, V., Shou, W., Matzuk, M. M., and Gordon, H. S. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 289: 1202, 1999.
12. Gold, B. G. FK506 and the role of the immunophilin FKBP-52 in nerve regeneration. Drug Metab. Rev. 31: 649, 1999.
13. Gold, B. G. Neuroimmunophilin ligands: Evaluation of their therapeutic potential for the treatment of neurological disorders. Expert Opin. Invest. Drugs 9: 2331, 2000.
14. Gold, B. G., Zeleny-Pooley, M., Wang, M. S., Chaturvedi, P., and Armistead, D. M. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147: 269, 1997.
15. Liu, J., Farmer, J. D., Lane, W. S., Weissman, I., and Schreiber, S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807, 1991.
16. O'Keefe, S. J., Tamura, J., Kincaid, R. L., Tocci, M. J., and O'Neill, E. A. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357: 692, 1992.
17. Armitage, J. M., Kormos, R. L., Morita, S., et al. Clinical trial of FK506 immunosuppression in adult cardiac transplantation. Ann. Thorac. Surg. 54: 205, 1992.
18. Dumont, F. J., Staruch, M. J., Koprak, S. L., et al. The immunosuppressive and toxic effects of FK-506 are mechanistically related: Pharmacology of a novel antagonist of FK-506 and rapamycin. J. Exp. Med. 176: 751, 1992.
19. Felldin, M., Backman, L., Brattstrom, C., et al. Rescue therapy with tacrolimus (FK506) in renal transplant recipients: A Scandinavian multicenter analysis. Transplant. Int. 10: 13, 1997.
20. Nielsen, F. T., Leyssac, P. P., Kemp, E., and Dieperink, H. Nephrotoxicity of FK-506 in the rat: Studies on glomerular and tubular function, and on the relationship, between efficacy and toxicity. Nephrol. Dial. Transplant. 10: 334, 1995.
21. Liu, J., Albers, M. W., Wandless, T. J., et al. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31: 3896, 1992.
22. Granelli-Piperna, A, and Nolan, P. Nuclear transcription factors that bind to elements of the IL-2 promoter: Induction requirements in primary human T cells. J. Immunol. 147: 2734, 1991.
23. Bram, R. J., Hung, D. T., Martin, P. K., Schreiber, S. L., and Crabtree, G. R. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: Roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13: 4760, 1993.
24. Kaye, R. E., Fruman, D. A., Bierer, B. E., et al. Effects of cyclosporin A and FK506 on Fcε receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: Resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc. Natl. Acad. Sci. U.S.A. 89: 8542, 1992.
25. Steiner, J. P., Dawson, T. M., Fotuhi, M., et al. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358: 584, 1992.
26. Lyons, W. E., Steiner, J. P., Snyder, S. H., and Dawson, T. M. Neuronal regeneration enhances the expression of the immunophilin FKBP-12. J. Neurosci. 15: 2985, 1995.
27. Goslin, K., Schrever, D. J., Skene, J. H., and Banker, G. Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones. Nature 336: 672, 1988.
28. Jacobson, R. D., Virag, I., and Skene, J. H. A protein associated with axon growth, GAP-43, is widely distributed and developmentally regulated in rat CNS. J. Neurosci. 6: 1843, 1986.
29. Skene, J. H. GAP-43 as a 'calmodulin sponge' and some implications for calcium signaling in axon terminals. Neurosci. Res. Suppl. 13: S112, 1990.
30. Wang, M. S., Zeleny-Pooley, M., and Gold, B. G. Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J. Pharmacol. Exp. Ther. 282: 1084, 1997.
31. Gold, B. G., Yew, J. Y., and Zeleny-Pooley, M. The immunosuppressant FK506 increases GAP-43 mRNA levels in axotomized sensory neurons. Neurosci. Lett. 241: 25, 1998.
32. Steiner, J. P., Connolly, M. A., Valentine, H. L., et al. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 3: 421, 1997.
33. Steiner, J. P., Hamilton, G. S., Ross, D. T., et al. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. U.S.A. 94: 2019, 1997.
34. Madsen, J. R., MacDonald, P., Irwin, N., et al. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 154: 673, 1998.
35. Sanchez, E. R. Hsp56: A novel heat shock protein associated with untransformed steroid receptor complexes. J. Biol. Chem. 265: 22067, 1990.
36. Czar, M. J., Galigniana, M. D., Silverstein, A. M., and Pratt, W. B. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus. Biochemistry 36: 7776, 1997.
37. Raaka, B. M., Finnerty, M., Sun, E., and Samuels, H. H. Effects of molybdate on steroid receptors in intact GH1 cells: Evidence for dissociation of an intracellular 10 S receptor oligomer prior to nuclear accumulation. J. Biol. Chem. 260: 14009, 1985.
38. Lagodzinski, Z., Gorski, A., and Wasik, M. Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice. Immunology 71: 148, 1990.
39. Inamura, N., Nakahara, K., Kino, T., et al. Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. Transplantation 45: 206, 1988.
40. Jones, N. D., Turvey, S. E., Van Maurik, A., et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J. Immunol. 166: 2824, 2001.
41. Suzuki, H., Patel, N., Matthews, M., DelRossi, A. J., Doolin, E. J., and Hewitt, C. W. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow. J. Surg. Res. 89: 176, 2000.